Glucocerebrosidase mutations in diffuse Lewy body disease()

Clinicogenetic and pathological studies have shown that mutations of the glucocerebrosidase gene (GBA) are a risk factor for Parkinson’s disease and Lewy body disorders. In the present study, we have identified GBA mutations in 6.8% (4/59) of cases with a pathological diagnosis of diffuse Lewy body...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Parkinsonism Relat Disord
Päätekijät: Nishioka, Kenya, Ross, Owen A., Vilariño-Güell, Carles, Cobb, Stephanie A., Kachergus, Jennifer M., Mann, David M.A., Snowden, Julie, Richardson, Anna M.T., Neary, David, Robinson, Christopher A., Rajput, Alex, Papapetropoulos, Spiridon, Mash, Deborah C., Pahwa, Rajesh, Lyons, Kelly E., Wszolek, Zbigniew K., Dickson, Dennis W., Farrer, Matthew J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2011
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4721925/
https://ncbi.nlm.nih.gov/pubmed/20971030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.parkreldis.2010.09.009
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia